BioSpace News Archive

Vertex Pharmaceuticals (Europe) Limited today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for ORKAMBI® (lumacaftor/ivacaftor) for the treatment of people with cystic fibrosis (CF) aged 2 to 5 years old who have two copies of the F508del mutation, the most common form of the disease.

WayAround®, the smart assistant for people with vision loss that gives on-demand details about everyday things, today debuted WayAround for Public Spaces at the Crystal Gateway Marriott in Alexandria, Virginia.

CBD Manufacturer to Support Semper K9 Non Pofit with 50 Percent Proceed Contribution

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that it will hold an investor conference call at 9:00 a.m. Eastern time on Monday, December 3, 2018.

AbbVie, a research-based global biopharmaceutical company, today announced a $55 million total donation to three leading nonprofits working to address the achievement gap for children in underserved areas

Donations to nonprofit hospitals and health care systems in the U.S. and Canada increased by $407 million during the 2017 fiscal year, totaling $12.082 billion, according to the Association for Healthcare Philanthropy’s (AHP) annual Report on Giving.

A year into new collaboration, Penn Medicine and Independence announce unprecedented results

Targovax ASA today announces that CMO Magnus Jäderberg will present at the NeoAg Summit 2018 (formerly Neoantigen Summit) in Boston

The Canadian Medical Association (CMA) is concerned with the Ontario government’s plan in Bill 47 to reinstate sick notes for short-term illnesses as a way to manage absenteeism.

Dr. Alex Hofmann, a trustee of the International Foundation for Patient Blood Management, recently spoke at the U.S.-China Health Summit held in Beijing, China, on October 12-14, 2018.